MSD's Keytruda bags approval for new skin cancer indication

26th June 2020 Uncategorised 0

In trials Keytruda showed ‘meaningful efficacy’ with an objective response rate of 34%

More: MSD's Keytruda bags approval for new skin cancer indication
Source: News